Mesoblast Limited (MESO) Announce 24-Patient Trial to Grow Heart Muscle in Children With Congenital Heart Disease at Harvard's Boston Children's Hospital
Tweet Send to a Friend
Boston Children’s Hospital, the pediatric teaching hospital of Harvard University, and Mesoblast Limited (NASDAQ: MESO) today announced that the United ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
